Topics

Cannabis Stock News: InterCure: Canndoc (TASE: INCR) signs strategic distribution agreement with S.L.E. of TEVA Pharmaceuticals (NYSE:$TEVA) (TASE: TEVA)

07:40 EDT 13 Sep 2019 | InvestorIdeas

HERZLIYA, Israel - September 13, 2019 (Investorideas.com Newswire) InterCure (TASE: INCR), announced that subsidiary Canndoc has entered into a strategic distribution agreement with Salomon, Levin, Elstein (S.L.E.,) which is owned by Teva Pharmaceuticals Industries (NYSE: and TASE: TEVA).

Original Article: Cannabis Stock News: InterCure: Canndoc (TASE: INCR) signs strategic distribution agreement with S.L.E. of TEVA Pharmaceuticals (NYSE:$TEVA) (TASE: TEVA)

NEXT ARTICLE

More From BioPortfolio on "Cannabis Stock News: InterCure: Canndoc (TASE: INCR) signs strategic distribution agreement with S.L.E. of TEVA Pharmaceuticals (NYSE:$TEVA) (TASE: TEVA)"

Quick Search

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...